Jiwei Wang

A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery

N. Lemoine, Yaohe Wang, Pengju Wang, 2020, Journal for ImmunoTherapy of Cancer.

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

N. Lemoine, Yaohe Wang, Pengju Wang, 2017, Nature Communications.

Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime

Zhe Zhang, N. Lemoine, Lirong Zhang, 2020, Frontiers in Immunology.

Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.

N. Lemoine, Yaohe Wang, R. Gangeswaran, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.

N. Lemoine, I. Fodor, Yaohe Wang, 2011, Human gene therapy.

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

N. Lemoine, Yaohe Wang, Pengju Wang, 2017, Nature Communications.

A Vaccinia Virus Armed with Interleukin-10 Is a Promising Therapeutic Agent for Treatment of Murine Pancreatic Cancer

T. Hagemann, N. Lemoine, I. Fodor, 2014, Clinical Cancer Research.

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain

Jing-xin Li, Binyang Zheng, Li Zhang, 2022, Human vaccines & immunotherapeutics.

A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer

Yaohe Wang, Y. Chu, Zhe Zhang, 2020, Molecular therapy oncolytics.